HOME >> BIOLOGY >> NEWS
Early treatment prevents lasting breathing problems in some premature babies

n uncertain.

The two new trials were conducted independently at different medical centers. Both involved infants born at less than 34 weeks of pregnancy who weighed between 500 and 1250 grams (about 1 pound to 3 pounds) at birth and who needed a ventilator to help them breathe. In one study, patients were treated with iNO within the first 48 hours of life; in the other study, treatment began between 1 week and 3 weeks of age. Combined, the studies reveal important benefits without adverse effects from iNO treatment.

"The findings from these two large, multicenter trials should help us better identify which babies might benefit from inhaled nitric oxide," noted Elizabeth G. Nabel, MD, director of NHLBI. "Successful and early treatment of breathing problems in these babies would represent a significant advance in improving the health and quality of life of a growing number of premature babies."

In the first study, nearly 800 babies were given either low-dose iNO or placebo (a harmless gas) starting within the first 48 hours of life and continuing through 21 days or until they no longer needed breathing assistance. Researchers found that the effects of iNO on survival without BPD were related to birthweight. Although treatment did not lower the overall incidence of BPD at 36 weeks, iNO appeared to cut the risk of BPD in half among the babies who weighed 1000 grams to 1250 grams (about 2.5 pounds) at birth.

In addition, significantly fewer babies treated with iNO developed brain damage, as indicated by head ultrasound. In particular, treated babies who weighed between 750 grams and 1000 grams (about 2 pounds) when they were born had half the risk of brain damage compared to babies of similar size who did not receive treatment.

"When given within the first 48 hours of life, low-dose inhaled nitric oxide reduced the risk of brain injury in very low birthweight premature newborns who required mechanical ventilation a
'"/>

Contact: NHLBI Communications Office
NHLBI_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
26-Jul-2006


Page: 1 2 3 4 5

Related biology news :

1. Early fire risk for mountains near Los Angeles
2. Early environmental exposure may accelerate age-related neurodegeneration
3. Early exposure to indoor fungus molecules may protect infants against future allergies
4. Early-stage sperm cells created from human bone marrow
5. Early Europeans unable to stomach milk
6. Early HIV treatment fails to restore memory T cells
7. Early Earth haze may have spurred life, says University of Colorado study
8. Early detection
9. Early family experience can reverse the effects of genes, UCLA psychologists report
10. Early to bed, early to rise
11. Early exposure to synthetic estrogen puts DES Daughters at higher risk for breast cancer

Post Your Comments:
(Date:6/19/2013)... further proof that the divergence of humans from chimpanzees ... profoundly influenced by mutations to DNA sequences that play ... study, published June 9 in Nature Genetics , ... genes must play an important role in evolution since ... the proteins produced by genes. Indeed, human and chimpanzee ...
(Date:6/19/2013)... 2012, the European Medicines Agency (EMA) approved the ... ever gene therapy for clinical use in the ... developed AAV-LPL S447X for the treatment of a ... (LPLD) which affects approximately one or two out ... life-threatening inflammations of the pancreas. Afflicted individuals carry ...
(Date:6/18/2013)... 2013  Paris Air Show – Marvin ... , a leading provider of innovative test solutions ... its solutions this week at the Paris ... challenges including increasingly complex armament systems with longer ... aerospace test solutions that address legacy system obsolescence. ...
Breaking Biology News(10 mins):New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3No danger of cancer through gene therapy virus 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3
(Date:6/18/2013)... , June 18, 2013 The "Bioinformatics ... Platforms, Knowledge Management Tools & Data Analysis Services) & Application ... studies the Major Market Drivers, Restraints, and Opportunities in ... Asia-Pacific and Rest of World. ... 22 Figures ...
(Date:6/18/2013)... -- Techne Corporation (NASDAQ: TECH ) (Techne) ... 100% ownership of Bionostics Holdings Limited and its ... global leader in the development, manufacture and distribution ... of in vitro diagnostic (IVD) devices ... and blood gas testing.  Biosnostics has strategic supply ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
(Date:6/18/2013)... , June 18, 2013   Lexicon ... a biopharmaceutical company focused on discovering breakthrough treatments ... Northcott has joined the company as its ... Mr. Northcott brings extensive commercial experience to Lexicon, ... a variety of therapeutic areas. Mr. ...
Breaking Biology Technology:Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
Cached News: